DR. NIKOLAOS J TSIOURIS M.D.
Prescription History 1790789428
Internal Medicine - Cardiovascular Disease in Las Vegas, NV

NPI Status: Active since June 10, 2005

Contact Information

700 SHADOW LN
SUITE #240
LAS VEGAS, NV
ZIP 89106
Phone: (702) 384-0022
Fax: (702) 384-0529

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. NIKOLAOS J TSIOURIS M.D., an active Cardiovascular Disease specialist practicing in Las Vegas, NV. Our medical registry currently tracks 24 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,226 documented patient claims. Among these therapy options, the most frequently utilized medication is Eliquis, which accounts for 197 claims alone.


Amiodarone Hcl

Generic Formulation: Amiodarone HclSpecialty: Cardiology
Provider Metrics Summary
Total Claims 37
30-Day Fills 84.0
Days Supply 2,474
NV State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills76.0
Peer Average Days Supply2,243
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,664.56 across this reporting matrix range.

Provider Avg Cost Per Claim

$44.99

State Avg Cost Per Claim

$31.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain types of serious (possibly fatal) irregular heartbeat (such as recurrent ventricular fibrillation/tachycardia). It is used to restore normal heart rhythm and maintain a regular, steady heartbeat. Amiodarone is known as an anti-arrhythmic drug. It works by blocking certain electrical signals in the heart that can cause an irregular heartbeat.

Amlodipine Besylate

Generic Formulation: Amlodipine BesylateSpecialty: Cardiology
Provider Metrics Summary
Total Claims 93
30-Day Fills 235.0
Days Supply 7,050
NV State Average Benchmarks
Peer Average Claims124.0
Peer Average 30-Day Fills328.8
Peer Average Days Supply9,822
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $583.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.27

State Avg Cost Per Claim

$7.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.

Therapeutic Applications

Amlodipine is used with or without other medications to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Amlodipine belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily. Amlodipine is also used to prevent certain types of chest pain (angina). It may help to increase your ability to exercise and decrease the frequency of angina attacks. It should not be used to treat attacks of chest pain when they occur. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor.

Atorvastatin Calcium

Generic Formulation: Atorvastatin CalciumSpecialty: Cardiology
Provider Metrics Summary
Total Claims 71
30-Day Fills 183.0
Days Supply 5,490
NV State Average Benchmarks
Peer Average Claims179.0
Peer Average 30-Day Fills485.7
Peer Average Days Supply14,506
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.3% less volume than the regional standard for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $787.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.09

State Avg Cost Per Claim

$11.71

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

Therapeutic Applications

Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Carvedilol

Generic Formulation: CarvedilolSpecialty: Cardiology
Provider Metrics Summary
Total Claims 66
30-Day Fills 138.0
Days Supply 4,140
NV State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills143.4
Peer Average Days Supply4,274
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $813.67 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.33

State Avg Cost Per Claim

$11.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION.

Therapeutic Applications

Carvedilol is used to treat high blood pressure and heart failure. It is also used after a heart attack to improve the chance of survival if your heart is not pumping well. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural substances in your body, such as epinephrine, on the heart and blood vessels. This effect lowers your heart rate, blood pressure, and strain on your heart. Carvedilol belongs to a class of drugs known as alpha and beta blockers.

Cephalexin

Generic Formulation: CephalexinSpecialty: Cardiology
Provider Metrics Summary
Total Claims 20
30-Day Fills 20.0
Days Supply 140
NV State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills29.2
Peer Average Days Supply315
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $140.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.02

State Avg Cost Per Claim

$10.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Clonidine Hcl

Generic Formulation: Clonidine HclSpecialty: Cardiology
Provider Metrics Summary
Total Claims 11
30-Day Fills 19.0
Days Supply 518
NV State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills51.6
Peer Average Days Supply1,487
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 56.0% less volume than the regional standard for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $75.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.88

State Avg Cost Per Claim

$10.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used alone or with other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Clonidine belongs to a class of drugs (central alpha agonists) that act in the brain to lower blood pressure. It works by relaxing blood vessels so blood can flow more easily.

Clopidogrel

Generic Formulation: Clopidogrel BisulfateSpecialty: Cardiology
Provider Metrics Summary
Total Claims 11
30-Day Fills 27.0
Days Supply 810
NV State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills113.5
Peer Average Days Supply3,379
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 75.6% less volume than the regional standard for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $204.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.56

State Avg Cost Per Claim

$16.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.

Therapeutic Applications

Clopidogrel is used to prevent heart attacks and strokes in persons with heart disease (recent heart attack), recent stroke, or blood circulation disease (peripheral vascular disease). It is also used with aspirin to treat new/worsening chest pain (new heart attack, unstable angina) and to keep blood vessels open and prevent blood clots after certain procedures (such as cardiac stent). Clopidogrel works by blocking platelets from sticking together and prevents them from forming harmful clots. It is an antiplatelet drug. It helps keep blood flowing smoothly in your body.

Digoxin

Generic Formulation: DigoxinSpecialty: Cardiology
Provider Metrics Summary
Total Claims 20
30-Day Fills 58.0
Days Supply 1,740
NV State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills75.6
Peer Average Days Supply2,241
Conservative Utilization

This provider writes prescriptions for this formulation 35.5% less frequently than the standard regional baseline metric for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,098.93 across this reporting matrix range.

Provider Avg Cost Per Claim

$54.95

State Avg Cost Per Claim

$31.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)

Therapeutic Applications

Digoxin is used to treat heart failure, usually along with other medications. It is also used to treat certain types of irregular heartbeat (such as chronic atrial fibrillation). Treating heart failure may help maintain your ability to walk and exercise and may improve the strength of your heart. Treating an irregular heartbeat can also improve your ability to exercise. Digoxin belongs to a class of medications called cardiac glycosides. It works by affecting certain minerals (sodium and potassium) inside heart cells. This reduces strain on the heart and helps it maintain a normal, steady, and strong heartbeat.

Diltiazem 24hr Er (Cd)

Generic Formulation: Diltiazem HclSpecialty: Cardiology
Provider Metrics Summary
Total Claims 38
30-Day Fills 72.0
Days Supply 2,160
NV State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills66.3
Peer Average Days Supply1,985
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 52.0% higher than the standard regional baseline profile for NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,689.19 across this reporting matrix range.

Provider Avg Cost Per Claim

$44.45

State Avg Cost Per Claim

$41.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Diltiazem is used to prevent chest pain (angina). It may help to increase your ability to exercise and decrease how often you may get angina attacks. Diltiazem is called a calcium channel blocker. It works by relaxing blood vessels in the body and heart and lowers the heart rate. Blood can flow more easily and your heart works less hard to pump blood.

Eliquis

Generic Formulation: ApixabanSpecialty: Cardiology
Provider Metrics Summary
Total Claims 197
30-Day Fills 334.8
Days Supply 10,009
NV State Average Benchmarks
Peer Average Claims65.0
Peer Average 30-Day Fills110.1
Peer Average Days Supply3,150
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 203.1% higher than the standard regional baseline profile for NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $198,789.41 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,009.08

State Avg Cost Per Claim

$881.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

Entresto

Generic Formulation: Sacubitril/ValsartanSpecialty: Cardiology
Provider Metrics Summary
Total Claims 99
30-Day Fills 127.0
Days Supply 3,810
NV State Average Benchmarks
Peer Average Claims49.0
Peer Average 30-Day Fills85.3
Peer Average Days Supply2,520
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 102.0% higher than the standard regional baseline profile for NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $89,991.61 across this reporting matrix range.

Provider Avg Cost Per Claim

$909.01

State Avg Cost Per Claim

$1,100.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This product is used to treat certain types of heart failure. It may help you live longer and lower your chance of having to go to the hospital for heart failure. This product contains 2 medications: sacubitril and valsartan. Sacubitril belongs to a class of drugs called neprilysin inhibitors and valsartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). They work by relaxing blood vessels so that blood can flow more easily, which makes it easier for your heart to pump blood to your body.

Farxiga

Generic Formulation: Dapagliflozin PropanediolSpecialty: Cardiology
Provider Metrics Summary
Total Claims 23
30-Day Fills 30.0
Days Supply 900
NV State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills65.5
Peer Average Days Supply1,950
Conservative Utilization

This provider writes prescriptions for this formulation 32.4% less frequently than the standard regional baseline metric for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $18,140.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$788.72

State Avg Cost Per Claim

$1,088.63

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys.

Furosemide

Generic Formulation: FurosemideSpecialty: Cardiology
Provider Metrics Summary
Total Claims 35
30-Day Fills 95.0
Days Supply 2,850
NV State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills122.6
Peer Average Days Supply3,588
Conservative Utilization

This provider writes prescriptions for this formulation 37.5% less frequently than the standard regional baseline metric for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $231.79 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.62

State Avg Cost Per Claim

$6.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.

Therapeutic Applications

Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt.

Hydrochlorothiazide

Generic Formulation: HydrochlorothiazideSpecialty: Cardiology
Provider Metrics Summary
Total Claims 31
30-Day Fills 57.0
Days Supply 1,710
NV State Average Benchmarks
Peer Average Claims63.0
Peer Average 30-Day Fills173.1
Peer Average Days Supply5,180
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 50.8% less volume than the regional standard for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $83.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.68

State Avg Cost Per Claim

$5.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.

Therapeutic Applications

This medication is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Hydrochlorothiazide belongs to a class of drugs known as diuretics/water pills. It works by causing you to make more urine. This helps your body get rid of extra salt and water. This medication also reduces extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, or kidney disease. This can lessen symptoms such as shortness of breath or swelling in your ankles or feet.

Isosorbide Mononitrate Er

Generic Formulation: Isosorbide MononitrateSpecialty: Cardiology
Provider Metrics Summary
Total Claims 13
30-Day Fills 37.0
Days Supply 1,110
NV State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills74.3
Peer Average Days Supply2,214
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 55.2% less volume than the regional standard for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $316.37 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.34

State Avg Cost Per Claim

$20.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease). This medication belongs to a class of drugs known as nitrates. It works by relaxing and widening blood vessels so blood can flow more easily to the heart. This medication will not relieve chest pain once it occurs. Also, it is not intended to be taken just before physical activities (such as exercise or sexual intercourse) to prevent chest pain. Other medications may be prescribed by your doctor for these conditions. Consult your doctor for more details.

Lisinopril

Generic Formulation: LisinoprilSpecialty: Cardiology
Provider Metrics Summary
Total Claims 106
30-Day Fills 244.0
Days Supply 7,298
NV State Average Benchmarks
Peer Average Claims110.0
Peer Average 30-Day Fills294.8
Peer Average Days Supply8,810
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,043.45 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.84

State Avg Cost Per Claim

$6.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.

Therapeutic Applications

Lisinopril is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily.

Losartan Potassium

Generic Formulation: Losartan PotassiumSpecialty: Cardiology
Provider Metrics Summary
Total Claims 31
30-Day Fills 79.0
Days Supply 2,370
NV State Average Benchmarks
Peer Average Claims109.0
Peer Average 30-Day Fills297.1
Peer Average Days Supply8,890
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 71.6% less volume than the regional standard for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $530.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.10

State Avg Cost Per Claim

$10.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.

Therapeutic Applications

Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.

Metoprolol Succinate

Generic Formulation: Metoprolol SuccinateSpecialty: Cardiology
Provider Metrics Summary
Total Claims 118
30-Day Fills 335.0
Days Supply 10,050
NV State Average Benchmarks
Peer Average Claims77.0
Peer Average 30-Day Fills208.4
Peer Average Days Supply6,234
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 53.2% higher than the standard regional baseline profile for NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,927.19 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.81

State Avg Cost Per Claim

$18.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

Therapeutic Applications

This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

Metoprolol Tartrate

Generic Formulation: Metoprolol TartrateSpecialty: Cardiology
Provider Metrics Summary
Total Claims 71
30-Day Fills 169.0
Days Supply 5,070
NV State Average Benchmarks
Peer Average Claims58.0
Peer Average 30-Day Fills143.9
Peer Average Days Supply4,282
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $617.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.69

State Avg Cost Per Claim

$8.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

Therapeutic Applications

Metoprolol is used with or without other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication is also used to treat chest pain (angina) and to improve survival after a heart attack. Metoprolol belongs to a class of drugs known as beta blockers. It works by blocking the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels. This effect lowers the heart rate, blood pressure, and strain on the heart.

Mexiletine Hcl

Generic Formulation: Mexiletine HclSpecialty: Cardiology
Provider Metrics Summary
Total Claims 29
30-Day Fills 64.6
Days Supply 1,920
NV State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills34.4
Peer Average Days Supply1,024
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 70.6% higher than the standard regional baseline profile for NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,943.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$239.42

State Avg Cost Per Claim

$211.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain types of serious (possibly fatal) irregular heartbeat (such as sustained ventricular tachycardia). It is used to restore normal heart rhythm and maintain a regular, steady heartbeat. Mexiletine is known as an anti-arrhythmic drug. It works by blocking certain electrical signals in the heart that can cause an irregular heartbeat. Treating an irregular heartbeat can decrease the risk for blood clots, and this effect can reduce your risk of heart attack or stroke.

Multaq

Generic Formulation: Dronedarone HclSpecialty: Cardiology
Provider Metrics Summary
Total Claims 17
30-Day Fills 31.0
Days Supply 930
NV State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills56.1
Peer Average Days Supply1,651
Conservative Utilization

This provider writes prescriptions for this formulation 43.3% less frequently than the standard regional baseline metric for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $23,720.43 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,395.32

State Avg Cost Per Claim

$1,360.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-iodinated derivative of amiodarone that is used for the treatment of ARRHYTHMIA.

Therapeutic Applications

This medication is used if you have had certain types of irregular heartbeat (paroxysmal or persistent atrial fibrillation) in the past but now have a normal heart rhythm. It helps you keep a normal heart rhythm and lowers your chance of having to go to the hospital for atrial fibrillation. Dronedarone is known as an antiarrhythmic drug. This medication should not be used if you have permanent atrial fibrillation because of the increased risk of very serious side effects. See also Warning section.

Potassium Chloride

Generic Formulation: Potassium ChlorideSpecialty: Cardiology
Provider Metrics Summary
Total Claims 22
30-Day Fills 40.0
Days Supply 1,200
NV State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills102.8
Peer Average Days Supply3,015
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.2% less volume than the regional standard for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $319.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.51

State Avg Cost Per Claim

$27.87

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA.

Therapeutic Applications

This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with water pills/diuretics.

Spironolactone

Generic Formulation: SpironolactoneSpecialty: Cardiology
Provider Metrics Summary
Total Claims 15
30-Day Fills 43.0
Days Supply 1,290
NV State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills90.1
Peer Average Days Supply2,686
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.3% less volume than the regional standard for practitioners inside NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $110.62 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.37

State Avg Cost Per Claim

$14.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)

Therapeutic Applications

Spironolactone is used to treat high blood pressure and heart failure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (such as heart failure, liver disease) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat conditions in which the body is making too much of a natural substance (aldosterone). Spironolactone is known as a water pill (potassium-sparing diuretic).

Xarelto

Generic Formulation: RivaroxabanSpecialty: Cardiology
Provider Metrics Summary
Total Claims 52
30-Day Fills 112.0
Days Supply 3,360
NV State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills78.2
Peer Average Days Supply2,284
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 30.0% more claims than the standard regional baseline profile for NV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $64,826.89 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,246.67

State Avg Cost Per Claim

$1,015.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.

Therapeutic Applications

Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. NIKOLAOS J TSIOURIS M.D. provides transparency into local medical care patterns within Las Vegas, NV.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Cardiovascular Disease** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.